Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

• Main Authors: Jose Navarro-Partida (Author), Juan Carlos Altamirano-Vallejo (Author), Luis Abraham Aceves Franco (Author), Jesús Gonzalez-Cortes (Author), Sergio Hernandez-Da Mota (Author), Jose Gerardo García-Aguirre (Author), Carlos David Azuara-Galindo (Author), Carlos Rodrigo Castro-Castaneda (Author), Juan Armendariz-Borunda (Author), Arturo Santos (Author)
• Format: Book
• Published: MDPI AG, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Novel strategies have been developed to reduce or avoid intravitreal injections (IVTs) of the antiangiogenic (ranibizumab (RBZ)) and anti-inflammatory (triamcinolone acetonide (TA)) agents used to treat vitreoretinal diseases. One of the strategies includes liposomes. This study evaluated the safety...